Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01998594 · ClinicalTrials.gov registry record · Phase 4
Use of FlexHD as Post Trapeziectomy Spacer
A Phase 4 study of Osteoarthrosis of the Carpometacarpal Joint of the Thumb, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01998594 is a Phase 4 study of Osteoarthrosis of the Carpometacarpal Joint of the Thumb that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01998594, a Phase 4 study of Osteoarthrosis of the Carpometacarpal Joint of the Thumb, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to show that using FlexHD® (or HADM) to fill the empty space created by removal of the trapezium improves the subject's outcome and subsequent functionality of the basilar joint arthroplasty procedure.
Conditions Studied
Interventions
- PROCEDURE Arthroplasty
Study Locations (1)
California
- Cedars-Sinai Department of Hand Surgery - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01998594
The ClinicalTrials.gov registry entry for NCT01998594 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthrosis of the Carpometacarpal Joint of the Thumb appearing as the primary indexed condition, and to 1 intervention - of which Arthroplasty is the first listed.
NCT01998594 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01998594 about?
NCT01998594 is a clinical study titled "Use of FlexHD as Post Trapeziectomy Spacer". The objective of this study is to show that using FlexHD® (or HADM) to fill the empty space created by removal of the trapezium improves the subject's outcome and subsequent functionality of the basilar joint arthroplasty procedure.
What is the current status of trial NCT01998594?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2013-08. Estimated completion is 2017-12.
What conditions does trial NCT01998594 study?
This clinical trial studies the following conditions: Osteoarthrosis of the Carpometacarpal Joint of the Thumb.
What interventions are being tested in trial NCT01998594?
The interventions under investigation include: Arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01998594?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01998594 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthrosis of the Carpometacarpal Joint of the Thumb
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.